AI assistant
MEMPHASYS LIMITED. — Capital/Financing Update 2017
Dec 21, 2017
65314_rns_2017-12-21_f9c910f4-15e0-42d4-9bd4-2a7a282904a3.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [222 x 64] intentionally omitted <==
ASX Release
$400,000 Special Grant received from the NSW Medical Devices Fund for the development of the Felix device.
Sydney, Friday 22 December 2017
Memphasys Limited (ASX:MEM) (“Memphasys” or “Company”) is pleased to announce that the Company has received the special grant of $400,000 from the NSW Medical Devices Fund (“NSWMDF”) that it had been offered, as announced on 24 November 2017. The grant is to advance the development of the Felix device for human in-vitro fertilization.
The Felix product, a next generation device that automates the separation of the ‘best’ sperm from a semen sample, also has application to both human and animal fertility.
The NSWMDF is a fund administered by the NSW Department of Health and Medical Research and is highly competitive. The grant offer was provided based on the decision to award the grant by an expert judging panel.
The Company will now move forward to meet near-term key milestones in the development of the Felix device which have been agreed under the terms of the grant.
Further information about the grant was provided in an ASX Announcement dated 24 November 2017.
For further information please contact:
Alison Coutts Executive Chairman +61 2 8415 7300 [email protected]
About Memphasys:
Memphasys Limited (ASX: MEM) specialises in biological separations for high value commercial applications. The Company’s patented membrane processes in combination with electrophoresis, the application of an electrical potential difference across a fluid, enable the separation of high value substances or contaminants from the fluid in which they are contained.
The main application of the technology is the separation of the most viable sperm cells for artificial reproduction, most particularly for human IVF.
Postal Address Contact Details E [email protected] P.O. Box 2202 P +612 8415 7300 W memphasys.com Homebush West NSW 2140 F +612 8415 7399 ABN 33 120 047 556
Memphasys Limited 30-32 Richmond Road Homebush West NSW 2140